Hoth Therapeutics, Inc. — Director's Dealing 2020

Feb 14, 2020

SEC Form 5 — Annual Statement of Changes in Beneficial Ownership

Issuer: Hoth Therapeutics, Inc. (HOTH)
CIK: 0001711786
Period of Report: 2019-12-31

Reporting Person: Knie Robb (Director, CEO and President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-10-28	Common Stock	J	85	—	Acquired	808255	Direct

Footnotes

F1: On October 28, 2019, Spherix Incorporated ("Spherix") distributed shares of the Issuer's common stock on a pro rata basis to its stockholders of record as of October 21, 2019 (the "Record Date"). Stockholders of Spherix received 1 share of the Issuer's common stock for each 29 shares of Spherix common stock held by such stockholders as of the Record Date.